Swiss National Bank
SLDB icon

Swiss National Bank’s Solid Biosciences SLDB Stock Holding History

Swiss National Bank’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,640
Closed -$95K – 2499
2020
Q1 		$95K Hold
2,640
– – ﹤0.01% 2470
2019
Q4 		$176K Buy
2,640
+760
+40% +$83.9K ﹤0.01% 2505
2019
Q3 		$292K Hold
1,880
– – ﹤0.01% 2459
2019
Q2 		$162K Hold
1,880
– – ﹤0.01% 2552
2019
Q1 		$259K Hold
1,880
– – ﹤0.01% 2479
2018
Q4 		$756K Buy
+1,880
New +$884K ﹤0.01% 2153

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Swiss National Bank's SLDB Position: Q2 2020 in Review

Swiss National Bank sold out of Solid Biosciences (SLDB) in Q2 2020, closing a stake of 2,640 shares — an estimated $95K sold.

Swiss National Bank first reported a position in SLDB in Q4 2018 and held it in 6 quarters. The position peaked at $756K in Q4 2018. 66 funds tracked by Wall St. Rank hold SLDB as of Q2 2020.

  • Swiss National Bank reported no remaining Solid Biosciences position as of Q2 2020 after selling out during the quarter.
  • Swiss National Bank sold 2,640 Solid Biosciences shares in Q2 2020, an estimated $95K.
  • Swiss National Bank first reported a position in Solid Biosciences in Q4 2018 and held it in 6 quarters.
  • Swiss National Bank's Solid Biosciences position peaked at $756K in Q4 2018.
  • 66 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2020.

Based on Swiss National Bank's 13F filing for Q2 2020, filed 5 Aug 2020.